What You Should Know:
– Quris-AI, a leading Bio-AI company revolutionizing drug development, has acquired Nortis, a pioneer in microphysiology systems (MPS) technology, formerly known as Numa Biosciences.
– The strategic acquisition will integrate Nortis’s advanced…
Continue Reading
Introduction
In a significant advancement for personalized medicine, GE HealthCare’s MIM Software has received FDA 510(k) clearance for its Theranostics portfolio. This clearance allows MIM SurePlan MRT to perform absorbed dose calculations using the Monte…
New AI Technology Enhances Cancer Treatment: Introduction
In the field of cancer treatment, personalized medicine has become a crucial focus, with immunotherapy revolutionizing the treatment of many cancers. However, predicting which patients will respond positively…
In the rapidly evolving landscape of healthcare, personalized medicine is making waves by offering tailored therapies that cater to the unique needs of individual patients. One of the most promising advancements in this field…
Continue Reading
What You Should Know:
– Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.
– Leveraging the power of Paige’s Foundation…
Continue Reading
Digital twins, innovative virtual models synthesizing real-time biological, environmental, and lifestyle data, herald a new era in personalized medicine, particularly dermatology. These models, integrating medical-purpose Internet of Things (IoT) devices, deep and digital phenotyping,…
Continue Reading
The following is a guest article by Dave Werry, Co-Founder & President at Well
Personalized healthcare continues to become more ubiquitous, and its well-documented benefits include greater health outcomes, enhanced convenience, and reduced employer costs….
What You Should Know: – Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care. – The survey of 475 patients explored attitudes…
Continue Reading
Cleveland Clinic and the Novo Nordisk Foundation have announced a new academic partnership focusing on leading-edge IT research and its clinical applications. The three-year opportunity is aimed at early-stage researchers working at the intersection…
Continue Reading
Dr. Elizabeth Reed Aden, a PHD and a former pharma industry executive and the author of The Goldilock Genome joins eHealth Radio and the Health News and Pharmaceutical Channels.
Listen to interview with host Eric…
